Test Article
|
Matrix
|
Species
|
Anticoagulant
|
Assay Type
|
LLOQ-ULOQ
|
Acetaminophen |
Plasma |
Human |
EDTA |
LC-MS/MS |
4-2000 |
Acetaminophen |
Plasma |
Human |
EDTA |
MS |
4-2000 |
Bupivacaine |
Plasma |
Human |
EDTA |
LC-MS/MS |
0.5-500 |
Hydrocodone |
Plasma |
Human |
EDTA |
LC-MS/MS |
0.2-100 |
Hydrocodone |
Plasma |
Human |
EDTA |
LC-MS/MS |
0.2-100 |
Morphine |
Plasma |
Human |
EDTA |
LC-MS/MS |
0.02-10 |
Morphine and Metabolites |
Plasma |
Human or Dog |
EDTA |
LC-MS/MS |
1-500 |
Morphine-6β-D-Glucuronide |
Plasma |
Human |
EDTA |
LC-MS/MS |
0.1-50 |
Noroxycodone |
Plasma |
Human |
EDTA |
LC-MS/MS |
1-100 |
Noroxycodone |
Plasma |
Plasma |
EDTA |
LC-MS/MS |
0.1-100 |
Oxycodone |
Plasma |
Human |
EDTA |
LC-MS/MS |
0.1-100 |
Oxycodone |
Plasma |
Human |
EDTA |
LC-MS/MS |
0.1-100 |
Oxymorphone |
Plasma |
Human |
EDTA |
LC-MS/MS |
0.1-100 |
Oxymorphone |
Plasma |
Human |
EDTA |
LC-MS/MS |
0.1-100 |
Oxymorphone and 6β-Hydroxyoxymorphone Metabolite |
Plasma |
Human |
EDTA |
LC-MS/MS |
20-2000 |
Pseudoephedrine |
Plasma |
Human |
EDTA |
LC-MS/MS |
50-1000 |